NCT06544161View on ClinicalTrials.gov

EJV Occlusion Pressure Measurement to Assess Intravascular Volume in Cirrhotic Patients During IV Albumin Substitution

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 17, 2024

Primary Completion Date

May 7, 2025

Study Completion Date

May 7, 2025

Conditions
Liver Cirrhosis
Interventions
DEVICE

CPMX2

The CPMX2 is a point-of-care device for non-invasive, real-time, and intermittent monitoring of vascular occlusion pressure.

Trial Locations (1)

3010

University Hospital Bern, Bern

Sponsors

Collaborators (1)

Compremium AG
All Listed Sponsors
collaborator

Compremium AG

INDUSTRY

lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT06544161 - EJV Occlusion Pressure Measurement to Assess Intravascular Volume in Cirrhotic Patients During IV Albumin Substitution | Biotech Hunter | Biotech Hunter